首页 > 最新文献

ASIAN CARDIOVASCULAR & THORACIC ANNALS最新文献

英文 中文
A conversation with the 2024 "Oriental Rising Star" awardee. 与2024年“东方之星”获奖者的对话。
IF 0.7 Q3 Medicine Pub Date : 2025-01-10 DOI: 10.1177/02184923241304159
Yuanjia Zhu, Song Wan

Aiming at encouraging young talents to become dedicated surgeon-scientists in the field of thoracic and cardiovascular surgery, an "Oriental Rising Star Award" was established at the 32nd annual meeting of the Asian Society for Cardiovascular and Thoracic Surgery ("ASCVTS 2024") which was held in Wuhan, China, on May 23-26, 2024. The winner of the First Prize was Dr. Yuanjia Zhu from Stanford University, USA. Following the conclusion of the "ASCVTS 2024," Professor Song Wan, Chairman of the Scientific Committee of the "ASCVTS 2025," conducted an interview with Dr. Zhu. Their conversation is presented below.

2024年5月23日至26日,在中国武汉举行的第32届亚洲心血管外科学会(ASCVTS 2024)年会上设立了“东方新星奖”,旨在鼓励年轻人才成为致力于胸外科和心血管外科领域的外科科学家。一等奖获得者为美国斯坦福大学朱元佳博士。“ASCVTS 2024”结束后,“ASCVTS 2025”科学委员会主席宋万教授对朱博士进行了采访。他们的对话如下。
{"title":"A conversation with the 2024 \"Oriental Rising Star\" awardee.","authors":"Yuanjia Zhu, Song Wan","doi":"10.1177/02184923241304159","DOIUrl":"https://doi.org/10.1177/02184923241304159","url":null,"abstract":"<p><p>Aiming at encouraging young talents to become dedicated surgeon-scientists in the field of thoracic and cardiovascular surgery, an \"Oriental Rising Star Award\" was established at the 32nd annual meeting of the Asian Society for Cardiovascular and Thoracic Surgery (\"ASCVTS 2024\") which was held in Wuhan, China, on May 23-26, 2024. The winner of the First Prize was Dr. Yuanjia Zhu from Stanford University, USA. Following the conclusion of the \"ASCVTS 2024,\" Professor Song Wan, Chairman of the Scientific Committee of the \"ASCVTS 2025,\" conducted an interview with Dr. Zhu. Their conversation is presented below.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"2184923241304159"},"PeriodicalIF":0.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bombay blood and the 'Swab-Lite' method of blood conservation. 孟买血液和“棉签- lite”血液保存方法。
IF 0.7 Q3 Medicine Pub Date : 2025-01-09 DOI: 10.1177/02184923251313563
Girish Rao, Shady Mohammed, Marya Mohamed, Yacob A Alkhulaifi, Cornelia S Carr

Bombay blood (hh blood) is a rare blood group (4 per million), with no expression of the H antigen present in blood group O. Bombay blood patients can only receive Bombay blood, with autodonation used for elective surgery. We present a Bombay patient (haemoglobin 12.1 g/dL) who needed urgent coronary artery bypass graft surgery. In order to try and avoid transfusion, we used a multidisciplinary approach as well as the use of 'no swabs' (swab/gauze/sponge), until cardiopulmonary bypass was established. This 'experiment' demonstrates that using fewer swabs may be a simple reproducible action that may reduce the need for transfusion, which is especially useful when dealing with a patient of such a rare blood group.

孟买血(hh blood)是一种罕见的血型(百万分之4),o血型中没有H抗原的表达。孟买血患者只能接受孟买血,自行捐献用于选择性手术。我们报告一位孟买病人(血红蛋白12.1 g/dL)需要紧急冠状动脉搭桥手术。为了尽量避免输血,我们使用了多学科方法以及“无拭子”(拭子/纱布/海绵),直到建立了体外循环。这个“实验”表明,使用更少的棉签可能是一个简单的可重复的行动,可能会减少输血的需要,这在治疗这种罕见血型的病人时尤其有用。
{"title":"Bombay blood and the 'Swab-Lite' method of blood conservation.","authors":"Girish Rao, Shady Mohammed, Marya Mohamed, Yacob A Alkhulaifi, Cornelia S Carr","doi":"10.1177/02184923251313563","DOIUrl":"https://doi.org/10.1177/02184923251313563","url":null,"abstract":"<p><p>Bombay blood (hh blood) is a rare blood group (4 per million), with no expression of the H antigen present in blood group O. Bombay blood patients can only receive Bombay blood, with autodonation used for elective surgery. We present a Bombay patient (haemoglobin 12.1 g/dL) who needed urgent coronary artery bypass graft surgery. In order to try and avoid transfusion, we used a multidisciplinary approach as well as the use of 'no swabs' (swab/gauze/sponge), until cardiopulmonary bypass was established. This 'experiment' demonstrates that using fewer swabs may be a simple reproducible action that may reduce the need for transfusion, which is especially useful when dealing with a patient of such a rare blood group.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"2184923251313563"},"PeriodicalIF":0.7,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fetuin-A as a plausible biomarker for cardiac valve calcification in rheumatic heart disease patients from North India. 胎儿素a可能是北印度风湿性心脏病患者心脏瓣膜钙化的生物标志物
IF 0.7 Q3 Medicine Pub Date : 2024-12-12 DOI: 10.1177/02184923241306482
Aishwarya Rani, Lakhwinder Singh, Anuradha Chakraborti, Sameer Gupta, Harkant Singh, Devinder Toor

Background: Rheumatic heart disease (RHD) remains a persistent public health challenge, particularly prevalent in developing and underdeveloped regions despite concerted global eradication efforts. The progressive stage of RHD, marked by valvular calcification, necessitates the imperative need to identify prognostic biomarkers. Fetuin-A, well-known for its role as a negative inhibitor of ectopic calcification, is investigated in our study as a potential biomarker for cardiac valve calcification in RHD patients.

Methods: Individuals with confirmed presence of RHD via echocardiography, who exhibited moderate to severe cardiac valve involvement, were enrolled alongside age and sex-matched healthy controls. Enzyme Linked Immunosorbent Assay was performed to analyse serum concentration of fetuin-A in healthy controls and RHD patients. Cytokine profiling was carried out using Cytometric Bead Array.

Results: Sixty confirmed RHD patients along with age and sex-matched case-control were evaluated for their serum fetuin-A and serum cytokines levels. Our findings reveal significantly reduced serum fetuin-A levels in RHD patients (1.96 ± 0.608 ng/ml) compared to healthy controls (2.85 ± 0.55 ng/ml) (p < 0.0001). Cytokine profiling shows nearly two-fold elevations in interleukin (IL)-17A, tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), IL-6, IL-10, IL-4 and IL-2 levels among RHD patients versus healthy controls, with IL-6 showing the maximum elevation in serum concentration. Pearson's correlation coefficient (r) values indicate a strong negative correlation between fetuin-A levels in RHD patients and various inflammatory cytokines, including IL-17A (-0.9754), IFN-γ (-0.8142), TNF-α (-0.8281), IL-10 (-0.9183), IL-6 (-0.8479), IL-4 (-0.9182) and IL-2 (-0.9430) (p < 0.05, statistically significant).

Conclusion: This study suggests that fetuin-A can be explored as a plausible biomarker for cardiac valve calcification and has an inverse correlation with inflammatory cytokines involved in RHD.

背景:风湿性心脏病(RHD)仍然是一个持续的公共卫生挑战,尽管全球一致努力根除,但在发展中国家和不发达地区尤其普遍。RHD的进展阶段,以瓣膜钙化为标志,迫切需要确定预后生物标志物。Fetuin-A因其作为异位钙化的负抑制剂而闻名,在我们的研究中被研究为RHD患者心脏瓣膜钙化的潜在生物标志物。方法:通过超声心动图确认存在RHD的个体,表现出中度至重度心脏瓣膜受累,与年龄和性别匹配的健康对照组一起入组。采用酶联免疫吸附法分析健康对照和RHD患者血清中胎儿素a的浓度。细胞因子谱分析采用细胞细胞阵列技术。结果:60例确诊的RHD患者以及年龄和性别匹配的病例对照评估了他们的血清胎儿素a和血清细胞因子水平。结果显示,RHD患者血清胎儿素a水平(1.96±0.608 ng/ml)显著低于健康对照组(2.85±0.55 ng/ml) (p r),表明RHD患者血清胎儿素a水平与多种炎症因子IL-17A(-0.9754)、IFN-γ(-0.8142)、TNF-α(-0.8281)、IL-10(-0.9183)、IL-6(-0.8479)、IL-4(-0.9182)、IL-2(-0.9430)呈显著负相关(p)。这项研究表明,胎儿素a可以作为心脏瓣膜钙化的一种合理的生物标志物,并且与RHD相关的炎症细胞因子呈负相关。
{"title":"Fetuin-A as a plausible biomarker for cardiac valve calcification in rheumatic heart disease patients from North India.","authors":"Aishwarya Rani, Lakhwinder Singh, Anuradha Chakraborti, Sameer Gupta, Harkant Singh, Devinder Toor","doi":"10.1177/02184923241306482","DOIUrl":"https://doi.org/10.1177/02184923241306482","url":null,"abstract":"<p><strong>Background: </strong>Rheumatic heart disease (RHD) remains a persistent public health challenge, particularly prevalent in developing and underdeveloped regions despite concerted global eradication efforts. The progressive stage of RHD, marked by valvular calcification, necessitates the imperative need to identify prognostic biomarkers. Fetuin-A, well-known for its role as a negative inhibitor of ectopic calcification, is investigated in our study as a potential biomarker for cardiac valve calcification in RHD patients.</p><p><strong>Methods: </strong>Individuals with confirmed presence of RHD via echocardiography, who exhibited moderate to severe cardiac valve involvement, were enrolled alongside age and sex-matched healthy controls. Enzyme Linked Immunosorbent Assay was performed to analyse serum concentration of fetuin-A in healthy controls and RHD patients. Cytokine profiling was carried out using Cytometric Bead Array.</p><p><strong>Results: </strong>Sixty confirmed RHD patients along with age and sex-matched case-control were evaluated for their serum fetuin-A and serum cytokines levels. Our findings reveal significantly reduced serum fetuin-A levels in RHD patients (1.96 ± 0.608 ng/ml) compared to healthy controls (2.85 ± 0.55 ng/ml) (<i>p</i> < 0.0001). Cytokine profiling shows nearly two-fold elevations in interleukin (IL)-17A, tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), IL-6, IL-10, IL-4 and IL-2 levels among RHD patients versus healthy controls, with IL-6 showing the maximum elevation in serum concentration. Pearson's correlation coefficient (<i>r</i>) values indicate a strong negative correlation between fetuin-A levels in RHD patients and various inflammatory cytokines, including IL-17A (-0.9754), IFN-γ (-0.8142), TNF-α (-0.8281), IL-10 (-0.9183), IL-6 (-0.8479), IL-4 (-0.9182) and IL-2 (-0.9430) (<i>p</i> < 0.05, statistically significant).</p><p><strong>Conclusion: </strong>This study suggests that fetuin-A can be explored as a plausible biomarker for cardiac valve calcification and has an inverse correlation with inflammatory cytokines involved in RHD.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"2184923241306482"},"PeriodicalIF":0.7,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical versus bioprosthetic valve for aortic valve replacement in dialysis patients: Systematic review and individual patient data meta-analysis. 透析患者主动脉瓣置换术的机械瓣膜与生物瓣膜:系统评价和个体患者数据荟萃分析。
IF 0.7 Q3 Medicine Pub Date : 2024-11-01 DOI: 10.1177/02184923241301108
Ioannis Zoupas, Georgios Loufopoulos, Panagiotis T Tasoudis, Vasiliki Manaki, Iosif Namidis, Thomas G Caranasos, Dimitrios C Iliopoulos, Thanos Athanasiou

Objective: There is little evidence regarding the most beneficial choice between a mechanical and a bioprosthetic valve in the aortic position in dialysis patients. This meta-analysis compares the survival and freedom from reintervention rates between mechanical and bioprosthetic valves in patients on dialysis undergoing aortic valve replacement surgery.

Methods: Two databases were searched, and the systematic review was performed in accordance with the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. We conducted one-stage and two-stage meta-analysis with Kaplan-Meier-derived individual patient data and meta-analysis with random-effects model.

Results: Eight studies were included, providing data about 1215 dialysis patients receiving mechanical valves and 1851 patients receiving bioprosthetic valves. During a mean follow-up of 43.1 months, overall survival rates were significantly improved in the mechanical valve group in comparison to the bioprosthetic one (hazard ratio [HR]: 0.76, 95% confidence interval [CI]: 0.69-0.84, p < 0.001). This was confirmed by the two-stage meta-analysis (HR: 0.72, 95% CI: 0.62-0.83, p = 0.00, I2 = 17.79%). Regarding freedom from reintervention, no arm offered a statistically significant advantage, according to the two-stage generated analysis (HR: 1.025, 95% CI: 0.65-1.61, p = 0.914). Similarly, there was no evident superiority of a valve type for perioperative outcomes.

Conclusions: Mechanical valves are likely to be associated with a better survival outcome compared to bioprosthetic valves for patients on dialysis undergoing aortic valve replacement. However, freedom from reoperation rates and perioperative outcomes were comparable between the two valve types, with no arm exhibiting a statistically significant advantage.

目的:关于透析患者主动脉位置机械瓣膜和生物假体瓣膜之间最有益的选择,几乎没有证据。这项荟萃分析比较了在接受主动脉瓣置换术的透析患者中,机械瓣膜和生物瓣膜的存活率和再干预率。方法:检索两个数据库,按照系统评价首选报告项目和meta分析声明的建议进行系统评价。我们使用kaplan - meier衍生的个体患者数据和随机效应模型进行了一期和两期meta分析。结果:纳入8项研究,提供1215例接受机械瓣膜的透析患者和1851例接受生物瓣膜的透析患者的数据。在平均43.1个月的随访中,机械瓣膜组的总生存率明显高于生物假体组(风险比[HR]: 0.76, 95%可信区间[CI]: 0.69-0.84, p < 0.001)。两阶段荟萃分析证实了这一点(HR: 0.72, 95% CI: 0.62-0.83, p = 0.00, I2 = 17.79%)。根据两阶段生成的分析,关于再干预的自由度,没有组具有统计学上显著的优势(HR: 1.025, 95% CI: 0.65-1.61, p = 0.914)。同样,对于围手术期的结果,瓣膜类型也没有明显的优势。结论:对于接受主动脉瓣置换术的透析患者,与生物瓣膜相比,机械瓣膜可能具有更好的生存结果。然而,两种瓣膜类型的再手术率和围手术期结果具有可比性,没有统计学上显著的优势。
{"title":"Mechanical versus bioprosthetic valve for aortic valve replacement in dialysis patients: Systematic review and individual patient data meta-analysis.","authors":"Ioannis Zoupas, Georgios Loufopoulos, Panagiotis T Tasoudis, Vasiliki Manaki, Iosif Namidis, Thomas G Caranasos, Dimitrios C Iliopoulos, Thanos Athanasiou","doi":"10.1177/02184923241301108","DOIUrl":"10.1177/02184923241301108","url":null,"abstract":"<p><strong>Objective: </strong>There is little evidence regarding the most beneficial choice between a mechanical and a bioprosthetic valve in the aortic position in dialysis patients. This meta-analysis compares the survival and freedom from reintervention rates between mechanical and bioprosthetic valves in patients on dialysis undergoing aortic valve replacement surgery.</p><p><strong>Methods: </strong>Two databases were searched, and the systematic review was performed in accordance with the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. We conducted one-stage and two-stage meta-analysis with Kaplan-Meier-derived individual patient data and meta-analysis with random-effects model.</p><p><strong>Results: </strong>Eight studies were included, providing data about 1215 dialysis patients receiving mechanical valves and 1851 patients receiving bioprosthetic valves. During a mean follow-up of 43.1 months, overall survival rates were significantly improved in the mechanical valve group in comparison to the bioprosthetic one (hazard ratio [HR]: 0.76, 95% confidence interval [CI]: 0.69-0.84, <i>p</i> < 0.001). This was confirmed by the two-stage meta-analysis (HR: 0.72, 95% CI: 0.62-0.83, <i>p</i> = 0.00, <i>I</i><sup>2</sup> = 17.79%). Regarding freedom from reintervention, no arm offered a statistically significant advantage, according to the two-stage generated analysis (HR: 1.025, 95% CI: 0.65-1.61, <i>p</i> = 0.914). Similarly, there was no evident superiority of a valve type for perioperative outcomes.</p><p><strong>Conclusions: </strong>Mechanical valves are likely to be associated with a better survival outcome compared to bioprosthetic valves for patients on dialysis undergoing aortic valve replacement. However, freedom from reoperation rates and perioperative outcomes were comparable between the two valve types, with no arm exhibiting a statistically significant advantage.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":"32 8-9","pages":"484-493"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accidental finding of ALCAPA in a child with severe mitral regurgitation: A case study. 一名患有严重二尖瓣返流的儿童意外发现 ALCAPA:病例研究。
IF 0.7 Q3 Medicine Pub Date : 2024-11-01 Epub Date: 2024-11-03 DOI: 10.1177/02184923241295550
Budi Rahmat, Radityo Prakoso, Rafles Ph Simbolon, Albert T Lopolisa, Muhammad Rayhan, Eva M Marwali

Case report: A six-year-old child who had undergone cardiac surgery five years ago presented to us with severe mitral valve regurgitation. During her current surgery, the coronary artery was injured during the attempt to release extensive epicardial adhesion, resulting in very poor contractility that prompted a delay in the intended valve repair. The injured coronary vessels were successfully repaired, yet low cardiac output syndrome persisted during perioperative care, necessitating further investigation of the coronary problem. It was later discovered that the patient had anomalous left coronary artery from pulmonary artery (ALCAPA) syndrome.

Discussion: The presence of severe mitral regurgitation, pulmonary hypertension, and anatomical factors may have contributed to the delayed presentation and diagnosis in this case. The severity of mitral regurgitation and the most likely underlying mechanism indicates a low possibility of recovery following coronary repair alone, warranting the need for concomitant mitral surgery. Coronary and mitral repair were performed in this patient, resulting in a favorable outcome.

Conclusions: The management of ALCAPA presents unique challenges, especially in cases with delayed diagnosis. Proper diagnosis and tailored surgical approaches are crucial for achieving favorable outcomes in patients with ALCAPA.

病例报告一名六岁儿童五年前曾接受过心脏手术,现因严重的二尖瓣返流来我院就诊。在目前的手术中,她的冠状动脉在试图松解广泛的心外膜粘连时受伤,导致收缩力极差,从而延误了预定的瓣膜修复手术。受伤的冠状动脉已成功修复,但围术期护理期间仍存在低心输出量综合征,因此有必要进一步检查冠状动脉问题。后来发现患者患有肺动脉左冠状动脉异常(ALCAPA)综合征:讨论:严重二尖瓣反流、肺动脉高压和解剖学因素可能是导致该病例延迟出现和诊断的原因。二尖瓣反流的严重程度和最可能的潜在机制表明,单靠冠状动脉修补术恢复的可能性很低,因此需要同时进行二尖瓣手术。该患者接受了冠状动脉和二尖瓣修复术,结果良好:结论:ALCAPA的治疗面临独特的挑战,尤其是在诊断延迟的病例中。正确的诊断和有针对性的手术方法是ALCAPA患者获得良好预后的关键。
{"title":"Accidental finding of ALCAPA in a child with severe mitral regurgitation: A case study.","authors":"Budi Rahmat, Radityo Prakoso, Rafles Ph Simbolon, Albert T Lopolisa, Muhammad Rayhan, Eva M Marwali","doi":"10.1177/02184923241295550","DOIUrl":"10.1177/02184923241295550","url":null,"abstract":"<p><strong>Case report: </strong>A six-year-old child who had undergone cardiac surgery five years ago presented to us with severe mitral valve regurgitation. During her current surgery, the coronary artery was injured during the attempt to release extensive epicardial adhesion, resulting in very poor contractility that prompted a delay in the intended valve repair. The injured coronary vessels were successfully repaired, yet low cardiac output syndrome persisted during perioperative care, necessitating further investigation of the coronary problem. It was later discovered that the patient had anomalous left coronary artery from pulmonary artery (ALCAPA) syndrome.</p><p><strong>Discussion: </strong>The presence of severe mitral regurgitation, pulmonary hypertension, and anatomical factors may have contributed to the delayed presentation and diagnosis in this case. The severity of mitral regurgitation and the most likely underlying mechanism indicates a low possibility of recovery following coronary repair alone, warranting the need for concomitant mitral surgery. Coronary and mitral repair were performed in this patient, resulting in a favorable outcome.</p><p><strong>Conclusions: </strong>The management of ALCAPA presents unique challenges, especially in cases with delayed diagnosis. Proper diagnosis and tailored surgical approaches are crucial for achieving favorable outcomes in patients with ALCAPA.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"475-480"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful repair of infracardiac total anomalous pulmonary venous connection with nonconfluent bilateral pulmonary veins. 双侧肺静脉不汇合的心下全肺静脉连接异常修复手术获得成功。
IF 0.7 Q3 Medicine Pub Date : 2024-11-01 Epub Date: 2024-10-17 DOI: 10.1177/02184923241291917
Tomonori Ochiai, Hideki Tatewaki, Naoki Masaki, Sadahiro Sai

We report a rare case of an infracardiac-type total anomalous pulmonary venous connection with nonconfluent bilateral pulmonary veins in a patient diagnosed with heterotaxy syndrome with right atrial isomerism, mitral valve atresia, a single atrium, and double-outlet right ventricle. On the fourth day of life, the patient underwent successful repair using a sutureless technique. Two years after the surgery, the patient remained well without any signs of pulmonary venous obstruction.

我们报告了一例罕见的心下型全肺静脉连接异常和双侧肺静脉非汇合病例,患者被诊断为异位发育综合征,伴有右心房异位、二尖瓣闭锁、单心房和右心室双出口。患者出生后第四天,成功接受了无缝合技术修复手术。术后两年,患者的情况依然良好,没有任何肺静脉阻塞的迹象。
{"title":"Successful repair of infracardiac total anomalous pulmonary venous connection with nonconfluent bilateral pulmonary veins.","authors":"Tomonori Ochiai, Hideki Tatewaki, Naoki Masaki, Sadahiro Sai","doi":"10.1177/02184923241291917","DOIUrl":"10.1177/02184923241291917","url":null,"abstract":"<p><p>We report a rare case of an infracardiac-type total anomalous pulmonary venous connection with nonconfluent bilateral pulmonary veins in a patient diagnosed with heterotaxy syndrome with right atrial isomerism, mitral valve atresia, a single atrium, and double-outlet right ventricle. On the fourth day of life, the patient underwent successful repair using a sutureless technique. Two years after the surgery, the patient remained well without any signs of pulmonary venous obstruction.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"472-474"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylactic 24 versus 48 h cephalosporins in cardiac surgery: A randomized trial. 心脏手术中 24 小时预防性头孢菌素与 48 小时预防性头孢菌素的比较:随机试验。
IF 0.7 Q3 Medicine Pub Date : 2024-11-01 Epub Date: 2024-11-10 DOI: 10.1177/02184923241297219
Mohammed Koudieh, Shukri Al Saif, Farouk Oueida, Abdulaziz Baradai, Khalid Alkhamees, Abdullah Otabi, Hatem Al Tahir, Hesham Younis, Ghada Al Qudaihi, Mostafa Essa, Tarek Maharem, Mostafa Fadel, Dina Al Balwai, Khalid Eskander

Background: Recommendations for cardiac surgery advocate for antibiotic prophylaxis for up to 48 hour after surgery. However, recent reports found a significant reduction in surgical site infection with extended duration. We evaluated the effect of the type of prophylactic antibiotics and administration durations on the postoperative surgical site infection rate following cardiac surgery in adults.

Methods: An investigator-initiated randomized controlled trial was conducted from 2018 to 2022 on adult patients undergoing cardiac surgery. Patients were randomized into four groups based on antibiotic treatment type and duration: 24 h cefazolin, 24 h cefuroxime, 48 h cefazolin, and 48 h cefuroxime. The primary outcome was the rate of surgical site infections within 90 days of surgery.

Results: A total of 568 patients were included in this study. The four groups had similar baseline characteristics, including age, sex, EuroSCORE II, and baseline HbA1c. A total of 75 patients developed infection within 90 days postoperative. The overall infection rate was not statistically different across the four groups (p = 0.193). The efficacy of cefazolin and cefuroxime in reducing infection was comparable (p = 0.901). Extended prophylaxis was associated with a significantly reduced overall infection rate within 90 days postoperatively compared to 24-h prophylaxis (10.2% vs. 16.3%; risk ratio = 0.62, 95% confidence interval: 0.40-0.96, p = 0.032).

Conclusion: Using cefazolin or cefuroxime for 48 h instead of 24 h was more effective in reducing the overall surgical site infections rate up to 90 days after surgery.

背景:心脏手术建议在术后 48 小时内使用抗生素预防。然而,最近的报告发现,延长用药时间可显著减少手术部位感染。我们评估了预防性抗生素的类型和用药时间对成人心脏手术后手术部位感染率的影响:2018年至2022年,研究者发起了一项随机对照试验,对象是接受心脏手术的成人患者。根据抗生素治疗类型和持续时间将患者随机分为四组:24 小时头孢唑啉、24 小时头孢呋辛、48 小时头孢唑啉和 48 小时头孢呋辛。主要结果是手术后 90 天内的手术部位感染率:本研究共纳入了 568 名患者。四组患者的基线特征相似,包括年龄、性别、EuroSCORE II 和基线 HbA1c。共有 75 名患者在术后 90 天内发生感染。四组的总体感染率无统计学差异(P = 0.193)。头孢唑啉和头孢呋辛在减少感染方面的疗效相当(p = 0.901)。与24小时预防相比,延长预防可显著降低术后90天内的总感染率(10.2%对16.3%;风险比=0.62,95%置信区间:0.40-0.96,p=0.032):结论:使用头孢唑啉或头孢呋辛 48 小时而不是 24 小时能更有效地降低术后 90 天内的手术部位感染率。
{"title":"Prophylactic 24 versus 48 h cephalosporins in cardiac surgery: A randomized trial.","authors":"Mohammed Koudieh, Shukri Al Saif, Farouk Oueida, Abdulaziz Baradai, Khalid Alkhamees, Abdullah Otabi, Hatem Al Tahir, Hesham Younis, Ghada Al Qudaihi, Mostafa Essa, Tarek Maharem, Mostafa Fadel, Dina Al Balwai, Khalid Eskander","doi":"10.1177/02184923241297219","DOIUrl":"10.1177/02184923241297219","url":null,"abstract":"<p><strong>Background: </strong>Recommendations for cardiac surgery advocate for antibiotic prophylaxis for up to 48 hour after surgery. However, recent reports found a significant reduction in surgical site infection with extended duration. We evaluated the effect of the type of prophylactic antibiotics and administration durations on the postoperative surgical site infection rate following cardiac surgery in adults.</p><p><strong>Methods: </strong>An investigator-initiated randomized controlled trial was conducted from 2018 to 2022 on adult patients undergoing cardiac surgery. Patients were randomized into four groups based on antibiotic treatment type and duration: 24 h cefazolin, 24 h cefuroxime, 48 h cefazolin, and 48 h cefuroxime. The primary outcome was the rate of surgical site infections within 90 days of surgery.</p><p><strong>Results: </strong>A total of 568 patients were included in this study. The four groups had similar baseline characteristics, including age, sex, EuroSCORE II, and baseline HbA1c. A total of 75 patients developed infection within 90 days postoperative. The overall infection rate was not statistically different across the four groups (<i>p</i> = 0.193). The efficacy of cefazolin and cefuroxime in reducing infection was comparable (<i>p</i> = 0.901). Extended prophylaxis was associated with a significantly reduced overall infection rate within 90 days postoperatively compared to 24-h prophylaxis (10.2% vs. 16.3%; risk ratio = 0.62, 95% confidence interval: 0.40-0.96, <i>p</i> = 0.032).</p><p><strong>Conclusion: </strong>Using cefazolin or cefuroxime for 48 h instead of 24 h was more effective in reducing the overall surgical site infections rate up to 90 days after surgery.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"462-471"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of preoperative computed tomography scan on neurological outcomes in coronary artery bypass grafting patients: A propensity-score analysis. 术前计算机断层扫描对冠状动脉旁路移植术患者神经系统预后的影响:倾向分数分析
IF 0.7 Q3 Medicine Pub Date : 2024-11-01 Epub Date: 2024-10-21 DOI: 10.1177/02184923241292098
Mariano Cefarelli, Pietro Giorgio Malvindi, Olimpia Bifulco, Beatrice Buratto, Paolo Berretta, Carlo Zingaro, Filippo Capestro, Michele Danilo Pierri, Jacopo Alfonsi, Alessandro D'Alfonso, Marco Di Eusanio

Introduction: Neurological complications pose significant risks in coronary artery bypass grafting (CABG). This study explores the potential benefits of preoperative chest computed tomography (CT) in optimizing outcomes and reducing neurological events in high-risk CABG patients.

Methods: From January 2017 to June 2023, a retrospective cohort study of CABG patients categorized groups based on preoperative chest CT use. Multivariate analysis evaluated the associations between CT imaging and patient characteristics, followed by propensity match analysis to balance preoperative features across groups.

Results: The study included 1786 patients, with 435 having undergone preoperative CT and 1351 without. Propensity matching created two well-balanced groups of 413 patients each. At multivariate analysis, CT patients were elderly (71.1 ± 8.9 years; p = 0.03) with a higher incidence of pulmonary disease (19.5%; p < 0.01), peripheral arterial disease (29.2%; p < 0.01), and previous cerebrovascular disease (23.4%; p = 0.02). In the matched CT cohort, the perioperative cerebral stroke rate was 0.7% (vs. 1.9% in without preoperative CT [WCT] cohort; p = 0.223), and the 30-day mortality rate was 0.2% (vs. 1.7% in WCT cohort; p = 0.069). Patients who had a preoperative CT study presented a higher prevalence of porcelain aorta (6.3% vs. 1.5%; p = 0.0003) and required more often a no-touch aorta procedure (20.3% vs. 14.5%; p = 0.035).

Conclusions: Patients undergoing preoperative chest CT before CABG were typically older and had systemic atherosclerosis and pulmonary disease. Propensity-matched analysis indicated low mortality and perioperative cerebral stroke rates in these high-risk patients. These findings support the integration of chest CT into preoperative evaluations for high-risk patients to develop tailored strategies in coronary artery bypass surgery.

导言:神经系统并发症是冠状动脉旁路移植术(CABG)的重大风险。本研究探讨了术前胸部计算机断层扫描(CT)在优化高风险 CABG 患者预后和减少神经系统事件方面的潜在益处:从 2017 年 1 月到 2023 年 6 月,一项对 CABG 患者的回顾性队列研究根据术前胸部 CT 的使用情况进行了分组。多变量分析评估了CT成像与患者特征之间的关联,然后进行倾向匹配分析,以平衡各组患者的术前特征:该研究共纳入了 1786 名患者,其中 435 人接受了术前 CT 检查,1351 人未接受术前 CT 检查。倾向匹配产生了两组均衡的患者,每组 413 人。多变量分析显示,CT 患者年龄较大(71.1 ± 8.9 岁;P = 0.03),肺部疾病发病率较高(19.5%;P = 0.02)。在匹配的 CT 队列中,围手术期脑卒中发生率为 0.7%(与未进行术前 CT [WCT] 队列中的 1.9%相比;P = 0.223),30 天死亡率为 0.2%(与 WCT 队列中的 1.7%相比;P = 0.069)。接受术前 CT 检查的患者主动脉瓷化的发生率更高(6.3% 对 1.5%;P = 0.0003),需要进行无触点主动脉手术的比例更高(20.3% 对 14.5%;P = 0.035):结论:接受 CABG 术前胸部 CT 的患者通常年龄较大,患有全身动脉粥样硬化和肺部疾病。倾向匹配分析表明,这些高危患者的死亡率和围手术期脑卒中发生率较低。这些研究结果支持将胸部 CT 纳入高危患者的术前评估,以便为冠状动脉搭桥手术制定有针对性的策略。
{"title":"Impact of preoperative computed tomography scan on neurological outcomes in coronary artery bypass grafting patients: A propensity-score analysis.","authors":"Mariano Cefarelli, Pietro Giorgio Malvindi, Olimpia Bifulco, Beatrice Buratto, Paolo Berretta, Carlo Zingaro, Filippo Capestro, Michele Danilo Pierri, Jacopo Alfonsi, Alessandro D'Alfonso, Marco Di Eusanio","doi":"10.1177/02184923241292098","DOIUrl":"10.1177/02184923241292098","url":null,"abstract":"<p><strong>Introduction: </strong>Neurological complications pose significant risks in coronary artery bypass grafting (CABG). This study explores the potential benefits of preoperative chest computed tomography (CT) in optimizing outcomes and reducing neurological events in high-risk CABG patients.</p><p><strong>Methods: </strong>From January 2017 to June 2023, a retrospective cohort study of CABG patients categorized groups based on preoperative chest CT use. Multivariate analysis evaluated the associations between CT imaging and patient characteristics, followed by propensity match analysis to balance preoperative features across groups.</p><p><strong>Results: </strong>The study included 1786 patients, with 435 having undergone preoperative CT and 1351 without. Propensity matching created two well-balanced groups of 413 patients each. At multivariate analysis, CT patients were elderly (71.1 ± 8.9 years; <i>p </i>= 0.03) with a higher incidence of pulmonary disease (19.5%; <i>p </i>< 0.01), peripheral arterial disease (29.2%; <i>p </i>< 0.01), and previous cerebrovascular disease (23.4%; <i>p </i>= 0.02). In the matched CT cohort, the perioperative cerebral stroke rate was 0.7% (vs. 1.9% in without preoperative CT [WCT] cohort; <i>p </i>= 0.223), and the 30-day mortality rate was 0.2% (vs. 1.7% in WCT cohort; <i>p </i>= 0.069). Patients who had a preoperative CT study presented a higher prevalence of porcelain aorta (6.3% vs. 1.5%; <i>p </i>= 0.0003) and required more often a no-touch aorta procedure (20.3% vs. 14.5%; <i>p </i>= 0.035).</p><p><strong>Conclusions: </strong>Patients undergoing preoperative chest CT before CABG were typically older and had systemic atherosclerosis and pulmonary disease. Propensity-matched analysis indicated low mortality and perioperative cerebral stroke rates in these high-risk patients. These findings support the integration of chest CT into preoperative evaluations for high-risk patients to develop tailored strategies in coronary artery bypass surgery.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"443-450"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axillary-coronary artery bypass using a vein graft via the suprasternal route. 使用经胸骨上途径的静脉移植进行腋动脉-冠状动脉搭桥术。
IF 0.7 Q3 Medicine Pub Date : 2024-11-01 Epub Date: 2024-11-25 DOI: 10.1177/02184923241301109
Hideki Isa, Masahiro Tsutsui, Fumitaka Suzuki, Ryohei Ushioda, Shingo Kunioka, Hiroyuki Kamiya

Redo coronary artery bypass grafting after an in-situ right internal thoracic artery graft to the left anterior descending artery is challenging. For such a 52-year-old male patient with a history of mediastinitis, we performed redo bypass grafting of the right coronary artery using a saphenous vein graft and xiphoid resection via the suprasternal route with the left axillary artery as the inflow source and the graft were patent. The axillary artery is an inflow source for patients with inaccessible aorta. Combining the suprasternal route with a xiphoid resection provides a bail-out option.

原位右胸内动脉移植至左前降支动脉后,重新进行冠状动脉旁路移植手术具有挑战性。对于这样一位有纵隔炎病史的 52 岁男性患者,我们使用大隐静脉移植物和剑突切除术,经胸骨上途径重新进行了右冠状动脉旁路移植术,以左侧腋动脉作为入流源,并且移植物是通畅的。腋动脉是主动脉无法进入的患者的血流来源。将胸骨上途径与剑突切除术相结合,提供了一种保外方案。
{"title":"Axillary-coronary artery bypass using a vein graft via the suprasternal route.","authors":"Hideki Isa, Masahiro Tsutsui, Fumitaka Suzuki, Ryohei Ushioda, Shingo Kunioka, Hiroyuki Kamiya","doi":"10.1177/02184923241301109","DOIUrl":"10.1177/02184923241301109","url":null,"abstract":"<p><p>Redo coronary artery bypass grafting after an <i>in-situ</i> right internal thoracic artery graft to the left anterior descending artery is challenging. For such a 52-year-old male patient with a history of mediastinitis, we performed redo bypass grafting of the right coronary artery using a saphenous vein graft and xiphoid resection via the suprasternal route with the left axillary artery as the inflow source and the graft were patent. The axillary artery is an inflow source for patients with inaccessible aorta. Combining the suprasternal route with a xiphoid resection provides a bail-out option.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"481-483"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of fenestration versus none in extracardiac total cavopulmonary connection. 在心外全腔肺连接中进行瓣膜置入术与不进行瓣膜置入术的结果。
IF 0.7 Q3 Medicine Pub Date : 2024-11-01 Epub Date: 2024-10-23 DOI: 10.1177/02184923241292688
Noppon Taksaudom, Jakaparn Horsatidkul, Thitipong Tepsuwan, Apichat Tantraworasin, Rekwan Sittiwangkul, Amarit Phothikun

Background: Fenestrated total cavopulmonary connection has gained popularity due to its capacity to reduce systemic venous pressure and enhance cardiac output. However, there is ongoing debate about the immediate and long-term advantages of fenestration in this context.

Method: A retrospective cohort study was conducted involving 97 patients who underwent extracardiac total cavopulmonary connection at Chiang Mai University Hospital between January 1999 and December 2019. The patients were initially categorized into two groups: fenestrated (n = 71) and nonfenestrated (n = 26). After exclusion and reassignment, the long-term outcomes were analyzed for the fenestrated (n = 68) and nonfenestrated (n = 25) groups. To address potential confounding factors between the two groups, propensity scores were computed using logistic regression analysis.

Results: The study found no significant differences in preoperative and operative data. Immediate postoperative outcomes showed no significant variations in major complications, intensive care unit stay, oxygen saturation, and posttotal cavopulmonary connection pressure. In the long-term assessment, the fenestrated group demonstrated significantly lower rates of mortality, protein-losing enteropathy, liver mass, and cirrhosis. However, after employing a multilevel model stratified by propensity score analysis, only long-term mortality rate was significantly lower in the fenestrated group (hazard ratio = 0.12, 95% confidence interval = 0.02-0.97). Fenestration patency closed gradually through spontaneous closure and device intervention.

Conclusion: The study found no major differences in immediate postoperative outcomes. In the fenestrated cohort, significantly lower incidences of protein-losing enteropathy, liver mass, cirrhosis, and long-term mortality were observed. However, multilevel model stratified by propensity score analysis indicated that only the lower long-term mortality demonstrated a major effect.

背景:瓣膜全腔肺连接术因其能降低全身静脉压和提高心输出量而受到欢迎。然而,在这种情况下,关于瓣膜的近期和远期优势一直存在争议:一项回顾性队列研究涉及 1999 年 1 月至 2019 年 12 月期间在清迈大学医院接受心外全腔肺连接术的 97 名患者。这些患者最初被分为两组:有瘘管(71 人)和无瘘管(26 人)。在排除和重新分配后,对开窗组(n = 68)和非开窗组(n = 25)的长期结果进行了分析。为了解决两组之间潜在的混杂因素,研究人员使用逻辑回归分析法计算了倾向得分:研究发现,术前和手术数据无明显差异。术后近期结果显示,主要并发症、重症监护室住院时间、血氧饱和度和全腔肺连接后压力均无明显差异。在长期评估中,栅栏组的死亡率、蛋白丢失性肠病、肝脏肿块和肝硬化的发生率明显较低。然而,在采用倾向得分分析多层次模型分层后,只有瓣膜组的长期死亡率明显降低(危险比 = 0.12,95% 置信区间 = 0.02-0.97)。通过自发闭合和设备干预,瘘管通畅率逐渐关闭:结论:研究发现,术后即刻结果没有重大差异。结论:研究发现术后即刻预后无重大差异,但在瘘管队列中,蛋白质丢失性肠病、肝脏肿块、肝硬化和长期死亡率的发生率明显较低。然而,根据倾向得分分析建立的多层次分层模型表明,只有长期死亡率较低才显示出主要影响。
{"title":"Outcomes of fenestration versus none in extracardiac total cavopulmonary connection.","authors":"Noppon Taksaudom, Jakaparn Horsatidkul, Thitipong Tepsuwan, Apichat Tantraworasin, Rekwan Sittiwangkul, Amarit Phothikun","doi":"10.1177/02184923241292688","DOIUrl":"10.1177/02184923241292688","url":null,"abstract":"<p><strong>Background: </strong>Fenestrated total cavopulmonary connection has gained popularity due to its capacity to reduce systemic venous pressure and enhance cardiac output. However, there is ongoing debate about the immediate and long-term advantages of fenestration in this context.</p><p><strong>Method: </strong>A retrospective cohort study was conducted involving 97 patients who underwent extracardiac total cavopulmonary connection at Chiang Mai University Hospital between January 1999 and December 2019. The patients were initially categorized into two groups: fenestrated (<i>n</i> = 71) and nonfenestrated (<i>n</i> = 26). After exclusion and reassignment, the long-term outcomes were analyzed for the fenestrated (<i>n</i> = 68) and nonfenestrated (<i>n</i> = 25) groups. To address potential confounding factors between the two groups, propensity scores were computed using logistic regression analysis.</p><p><strong>Results: </strong>The study found no significant differences in preoperative and operative data. Immediate postoperative outcomes showed no significant variations in major complications, intensive care unit stay, oxygen saturation, and posttotal cavopulmonary connection pressure. In the long-term assessment, the fenestrated group demonstrated significantly lower rates of mortality, protein-losing enteropathy, liver mass, and cirrhosis. However, after employing a multilevel model stratified by propensity score analysis, only long-term mortality rate was significantly lower in the fenestrated group (hazard ratio = 0.12, 95% confidence interval = 0.02-0.97). Fenestration patency closed gradually through spontaneous closure and device intervention.</p><p><strong>Conclusion: </strong>The study found no major differences in immediate postoperative outcomes. In the fenestrated cohort, significantly lower incidences of protein-losing enteropathy, liver mass, cirrhosis, and long-term mortality were observed. However, multilevel model stratified by propensity score analysis indicated that only the lower long-term mortality demonstrated a major effect.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"451-461"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ASIAN CARDIOVASCULAR & THORACIC ANNALS
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1